Tamara Beetham is a PhD Candidate in health policy and management with a health economics concentration. Her research interests include healthcare access for those who are medically underserved and the effects of policy on treatment supply and quality, particularly with respect to the mental health and addiction treatment industries. She was awarded early investigator pilot funding by the National Institutes of Drug Abuse through RAND's Opioid Policy Tools and Information Center for Research Excellence. Her research has been published in journals such as JAMA, Health Affairs, Annals of Internal Medicine, and the Harvard Public Health Review, and has received coverage from National Public Radio, Associated Press, Reuters, and other media outlets . Her paper on access buprenorphine treatment for opioid use disorder was selected as one of ten "Best of Annals" in 2019 by the Editor-in-Chief of Annals of Internal Medicine. She holds an MPH from Harvard School of Public Health and a BA from the University of Colorado.